about
Human monoclonal antibody-based therapy in the treatment of invasive candidiasisCytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarminsAspergillus fumigatus and aspergillosisInsights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosisMeasurement of T-cell-derived antigen binding molecules and immunoglobulin G specific to Candida albicans mannan in sera of patients with recurrent vulvovaginal candidiasis.A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survivalMP1 encodes an abundant and highly antigenic cell wall mannoprotein in the pathogenic fungus Penicillium marneffei.Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in miceSpecific antibody to Cryptococcus neoformans alters human leukocyte cytokine synthesis and promotes T-cell proliferation.Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidisA vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection.Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cellsProduction of egg yolk antibodies specific to house dust mite proteinsAntibody response to Cryptococcus neoformans proteins in rodents and humans.A histoplasma capsulatum-specific IgG1 isotype monoclonal antibody, H1C, to a 70-kilodalton cell surface protein is not protective in murine histoplasmosis.Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-associated diseases.Characterization of AFMP1: a novel target for serodiagnosis of aspergillosis.Serologic response to cell wall mannoproteins and proteins of Candida albicansLow levels of antigenic variability in fluconazole-susceptible and -resistant Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis.In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.Molecular and idiotypic analyses of the antibody response to Cryptococcus neoformans glucuronoxylomannan-protein conjugate vaccine in autoimmune and nonautoimmune miceProtection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody.Monoclonal immunoglobulin G1 directed against Aspergillus fumigatus cell wall glycoprotein protects against experimental murine aspergillosisIntravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasisCandida-specific antibodies during experimental vaginal candidiasis in mice.Relationship of the glyoxylate pathway to the pathogenesis of Cryptococcus neoformansPrediction of the clinical outcome in invasive candidiasis patients based on molecular fingerprints of five anti-Candida antibodies in serumA fungicidal monoclonal antibody protects against murine invasive candidiasis.Hibernating little brown myotis (Myotis lucifugus) show variable immunological responses to white-nose syndrome.Hybridoma passage in vitro may result in reduced ability of antimannan antibody to protect against disseminated candidiasisRole of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis.Differential humoral response against alpha- and beta-linked mannose residues associated with tissue invasion by Candida albicans.Vaginal yeast colonisation, prevalence of vaginitis, and associated local immunity in adolescents.CD47 Promotes Protective Innate and Adaptive Immunity in a Mouse Model of Disseminated Candidiasis.Fungal Inositol Pyrophosphate IP7 Is Crucial for Metabolic Adaptation to the Host Environment and Pathogenicity.A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities.T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice.Immunoglobulins G, M, and A against Sporothrix schenckii exoantigens in patients with sporotrichosis before and during treatment with itraconazole.Anticandidal immunity and vaginitis: novel opportunities for immune intervention.
P2860
Q26864291-50D704DF-001E-4339-ACC0-845BFE7A4483Q27021956-605F56A6-8CC0-4C0B-97C7-BA3C1DB3C0AEQ29617908-4093F38F-4C4E-4476-B6C7-B400663B2CD0Q33499671-FC011BD7-08AF-48E9-BE91-C4882A6ACABCQ33595842-C249B39C-5AA9-4A32-A1FC-AE078CC72716Q33606785-DE2D0B58-4D17-4CF3-B9EA-AC5B8ABF67EBQ33751318-C6CEE10A-503A-41C7-8E92-419272B587B0Q33751509-630E6303-139A-4CA6-9A09-92F2654CB000Q33751838-854C4DC5-9CFE-480A-A421-324DACD3BD66Q33767890-6CD08DBB-2CE7-4031-8F4E-30C63E1771BEQ33768705-3AA2756A-4D2A-4962-A051-B0220FFEA902Q33793546-99A33324-E7A3-43E2-8741-1947369102CAQ33822620-E2812E84-BC04-45C8-9EBE-4E4C73C535BAQ33867027-04B59CB5-E86D-4494-B487-16EA04028B94Q33962651-A0DBEA00-C6F7-453A-A4D9-E94B49554F7EQ33972181-18C769BE-BBAF-4EEC-A2C8-1F6A1D64E9E6Q33973840-EED8C5BF-DDCB-44FE-B42A-D8BCBC8659D4Q33992594-33F2719B-094C-44A1-BECC-35B15316FC03Q33997849-7140A389-CB7C-4B2A-80A2-B02B18FD293AQ34000362-A196BCFF-C63F-4E25-9A89-B3D1A66E963CQ34001243-38B43243-6997-45D0-B7C2-16FF5DDF2D69Q34001701-55200887-4C2A-43DF-A4AF-7CD30A2D6AAAQ34003695-BA441EA7-41D2-4E38-8053-CBC507DF6BABQ34045440-26180672-8E18-40B1-9F83-D5F5FD904D0EQ34121150-FDCAA431-7C42-4009-9677-48486CDF0D40Q34131799-3A1CCA57-F6E5-40F4-8C07-529D806FBEA3Q34132857-271BE0A3-C32C-4D19-986B-C81B17C2213EQ34454950-8B6ED0BC-6248-483A-9A30-893CFB7ABD03Q34601994-48EE82A6-CD50-4326-93FD-4615307F8F73Q34634458-1D2B4D7D-CF88-45B7-8F1A-8DEEC100D698Q34721320-4D917FC2-F3EA-4A0A-B164-68DA76A58931Q35164284-538BB55F-DF09-4A99-BB4A-57614311B9AFQ35229630-A71896C8-FAE3-4A03-87A3-E5D3706B6261Q35562992-BA26D84E-E14D-4389-9D56-1DDB7042EF22Q35648733-D04949E1-1D32-4E8A-883A-323DC54BF252Q35676308-C59A696B-F383-4617-B783-9C839401C62AQ35802339-1A623B39-EADD-42C6-AE62-40CF2A138752Q36047782-37C61218-644E-472B-A2C3-C5A89E063859Q36095151-DE0B530F-04A7-4FA0-92C0-85DDE908C43FQ36097307-0D1C91F7-A88E-43AA-B32F-D1A2AC31BEC4
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Antibody immunity and invasive fungal infections
@ast
Antibody immunity and invasive fungal infections
@en
type
label
Antibody immunity and invasive fungal infections
@ast
Antibody immunity and invasive fungal infections
@en
prefLabel
Antibody immunity and invasive fungal infections
@ast
Antibody immunity and invasive fungal infections
@en
P2860
P1476
Antibody immunity and invasive fungal infections
@en
P2093
A Casadevall
P2860
P304
P407
P577
1995-11-01T00:00:00Z